| # | Drug | Count |
|---|---|---|
| 0 | LENALIDOMIDE | 21 |
| 1 | ROSUVASTATIN | 10 |
| 2 | ETANERCEPT | 9 |
| 3 | EVOLOCUMAB | 8 |
| 4 | ASPIRIN | 7 |
| 5 | ASPIRIN 325 MG | 7 |
| 6 | ASPIRIN 81 MG | 7 |
| 7 | DENOSUMAB | 7 |
| 8 | ADALIMUMAB | 6 |
| 9 | DAPAGLIFLOZIN | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SETMELANOTIDE | 1 | 0.0035 |
| 1 | TRIHEPTANOIN | 1 | 0.0018 |
| 2 | ATROPINE INJECTION, 2 MG | 1 | 0.0007 |
| 3 | ACALABRUTINIB | 5 | 0.0004 |
| 4 | LUSPATERCEPT | 1 | 0.0004 |
| 5 | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0003 |
| 6 | BARICITINIB | 1 | 0.0003 |
| 7 | CAPIVASERTIB | 1 | 0.0003 |
| 8 | DEFERIPRONE | 1 | 0.0003 |
| 9 | AVACOPAN | 2 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Thalidomide Analog [EPC] | 24 |
| 1 | Kinase Inhibitor [EPC] | 12 |
| 2 | HMG-CoA Reductase Inhibitor [EPC] | 10 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 10 |
| 4 | Corticosteroid [EPC] | 9 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 9 |
| 6 | Benzodiazepine [EPC] | 8 |
| 7 | PCSK9 Inhibitor [EPC] | 8 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 7 |
| 9 | Proton Pump Inhibitor [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 1 | Medium-chain Triglyceride [EPC] | 1 | 0.0018 |
| 2 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 2 | 0.0016 |
| 3 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 4 | Erythroid Maturation Agent [EPC] | 1 | 0.0004 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 6 | PCSK9 Inhibitor [EPC] | 8 | 0.0003 |
| 7 | Complement 5a Receptor Antagonist [EPC] | 2 | 0.0003 |
| 8 | Thymic Stromal Lymphopoietin Blocker [EPC] | 1 | 0.0001 |
| 9 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |